Harbour Investments’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $16.4K | Buy |
978
+366
| +60% | +$6.13K | ﹤0.01% | 2331 |
|
2025
Q1 | $9.41K | Sell |
612
-107
| -15% | -$1.65K | ﹤0.01% | 2553 |
|
2024
Q4 | $15.8K | Hold |
719
| – | – | ﹤0.01% | 2233 |
|
2024
Q3 | $13K | Buy |
719
+57
| +9% | +$1.03K | ﹤0.01% | 2243 |
|
2024
Q2 | $10.8K | Sell |
662
-225
| -25% | -$3.66K | ﹤0.01% | 2227 |
|
2024
Q1 | $12.5K | Hold |
887
| – | – | ﹤0.01% | 2140 |
|
2023
Q4 | $9.26K | Buy |
887
+168
| +23% | +$1.75K | ﹤0.01% | 2166 |
|
2023
Q3 | $7.33K | Buy |
719
+17
| +2% | +$173 | ﹤0.01% | 2152 |
|
2023
Q2 | $5.29K | Buy |
702
+60
| +9% | +$452 | ﹤0.01% | 2266 |
|
2023
Q1 | $5.68K | Sell |
642
-20
| -3% | -$177 | ﹤0.01% | 2227 |
|
2022
Q4 | $6.04K | Hold |
662
| – | – | ﹤0.01% | 2160 |
|
2022
Q3 | $5K | Hold |
662
| – | – | ﹤0.01% | 2204 |
|
2022
Q2 | $5K | Buy |
+662
| New | +$5K | ﹤0.01% | 2204 |
|
2021
Q4 | $5K | Sell |
612
-95
| -13% | -$776 | ﹤0.01% | 2198 |
|
2021
Q3 | $7K | Buy |
707
+65
| +10% | +$644 | ﹤0.01% | 2854 |
|
2021
Q2 | $6K | Buy |
642
+100
| +18% | +$935 | ﹤0.01% | 2991 |
|
2021
Q1 | $6K | Buy |
+542
| New | +$6K | ﹤0.01% | 2857 |
|